Temozolomide Treatment Increases Fatty Acid Uptake in Glioblastoma Stem Cells

Temozolomide Treatment Increases Fatty Acid Uptake in Glioblastoma Stem Cells

Among all cancers, glioblastoma (GBM) remains one of the least treatable. One key factor in this resistance is a subpopulation of tumor cells termed glioma stem cells (GSCs). These cells are highly resistant to current treatment modalities, possess marked self-renewal capacity, and are considered ke...

Full description

Bibliographic Details
Main Authors: Seamus Caragher, Jason Miska, Jack Shireman, Cheol H. Park, Megan Muroski, Maciej S. Lesniak, Atique U. Ahmed
Format: Article
Language:English
Published: MDPI AG 2020-10-01
Series:Cancers
Subjects:
glioblastoma
glioma stem cell
metabolism
therapeutic stress
chemoresistance
Online Access:https://www.mdpi.com/2072-6694/12/11/3126

Internet

https://www.mdpi.com/2072-6694/12/11/3126

Similar Items